A Selective, Orally Bioavailable1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor ofJanus Kinase 2 for Use inAnticancer Therapy: Discovery of CEP-33779.
| Autor: | Dugan, Benjamin J., Gingrich, Diane E., Mesaros, Eugen F., Milkiewicz, Karen L., Curry, Matthew A., Zulli, Allison L., Dobrzanski, Pawel, Serdikoff, Cynthia, Jan, Mahfuza, Angeles, Thelma S., Albom, Mark S., Mason, Jennifer L., Aimone, Lisa D., Meyer, Sheryl L., Huang, Zeqi, Wells-Knecht, Kevin J., Ator, Mark A., Ruggeri, Bruce A., Dorsey, Bruce D. |
|---|---|
| Zdroj: | Journal of Medicinal Chemistry; Jun2012, Vol. 55 Issue 11, p5243-5254, 12p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|